ONCSQ (OncoSec Medical) Accumulated Depreciation: $-1.64 Mil (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoSec Medical Accumulated Depreciation?

OncoSec Medical ONCSQ -90.00% Accumulated Depreciation is $-1.64 Mil as of Jan. 2023.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

OncoSec Medical's quarterly accumulated depreciation increased from Jul. 2022 ($-1.55 Mil) to Oct. 2022 ($-1.60 Mil) and increased from Oct. 2022 ($-1.60 Mil) to Jan. 2023 ($-1.64 Mil).

OncoSec Medical's annual accumulated depreciation increased from Jul. 2020 ($-1.18 Mil) to Jul. 2021 ($-1.37 Mil) and increased from Jul. 2021 ($-1.37 Mil) to Jul. 2022 ($-1.55 Mil).

OncoSec Medical Accumulated Depreciation Related Terms

OncoSec Medical Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Accumulated Depreciation Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.73 -0.96 -1.18 -1.37 -1.55

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.46 -1.51 -1.55 -1.60 -1.64

OncoSec Medical Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-1.64 Mil mean?
OncoSec Medical (ONCSQ) has a Accumulated Depreciation of $-1.64 Mil as of Jan. 2023. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Accumulated Depreciation too high?
OncoSec Medical's current Accumulated Depreciation is $-1.64 Mil.
How does OncoSec Medical's Accumulated Depreciation compare to NOVNQ and USRM?
OncoSec Medical's Accumulated Depreciation of $-1.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Accumulated Depreciation is $-1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Accumulated Depreciation of $-1.64 Mil. The current Accumulated Depreciation is $-1.64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Accumulated Depreciation is $-1.64 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.